BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., June 06, 2023 -- BioCryst Pharmaceuticals, Inc. today announced that the compensation committee of BioCryst’s board of directors granted 11 newly-hired... | June 6, 2023